
pmid: 16497577
The extraordinary genetic diversity and immune evasion of human immunodeficiency virus (HIV) pose significant challenges for vaccine development. AIDS vaccine design requires a scientifically driven, rational approach that encompasses the latest advances in viral molecular genetics, structural biology, and immunology.
AIDS Vaccines, Acquired Immunodeficiency Syndrome, Clinical Trials as Topic, Immunity, Cellular, Biochemistry, Genetics and Molecular Biology(all), Genetic Variation, Antibodies, Viral, Major Histocompatibility Complex, Models, Structural, Viral Proteins, HIV-1, Humans, Technology, Pharmaceutical, Forecasting
AIDS Vaccines, Acquired Immunodeficiency Syndrome, Clinical Trials as Topic, Immunity, Cellular, Biochemistry, Genetics and Molecular Biology(all), Genetic Variation, Antibodies, Viral, Major Histocompatibility Complex, Models, Structural, Viral Proteins, HIV-1, Humans, Technology, Pharmaceutical, Forecasting
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 125 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
